In addition, the possibility of using GM-CSF in the treatment of neurodegenerative diseases [4,5,6], immunotherapy of malignant diseases [7,8], and in autoimmune conditions [9,10] to accelerate wound healing [11,12,13] has recently been investigated. This evidence concerns the gene CSF2 and neurodegenerative disease.